By jpalfreyman on
Email
info@tennorx.com
ClinicalTrials.gov URL
https://clinicaltrials.gov/search?spons=TenNor%20Therapeutics%20Limited
Acknowledgement
NA
EA Page
https://www.tennorx.com/en/expandaccesspolicy.html
EA Therapies for Single Patient

At this time, TenNor will not provide investigational drug outside of clinical studies and will reevaluate when sufficient preliminary safety and efficacy information has been obtained in clinical trials.

Rifasutenizol (formerly known as TNP-2198) is currently under clinical development for the treatment of Helicobacter pylori infection. Rifaquizinone (formerly known as TNP-2092) is currently under clinical development for the treatment of Prosthetic Joint infection (PJI) and Acute Bacterial Skin and Skin Structure Infections (ABSSSI).


At this time, TenNor will not provide investigational drug outside of clinical studies and will reevaluate when sufficient preliminary safety and efficacy information has been obtained in clinical trials.